A failure analysis of invasive breast cancer: Most deaths from disease occur in women not regularly screened

By  

CANCER, Vol. 120, Iss. 18, 2014-09 ,pp. : 2936-2937

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to differences in 25‐hydroxyvitamin D concentrations may explain most of the black‐white breast cancer disparities noted in young women

By  

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 2098-2098

John Wiley & Sons Inc

Access to resources Recommend Favorite

Microenvironmental Influences that Drive Progression from Benign Breast Disease to Invasive Breast Cancer

By Cichon Magdalena  

Journal of Mammary Gland Biology and Neoplasia, Vol. 15, Iss. 4, 2010-12 ,pp. : 389-397

Springer Publishing Company

Access to resources Recommend Favorite

Should healthy populations be screened for breast cancer? A perspective from someone with previously diagnosed breast cancer

By Blennerhassett Mitzi  

Quality in Primary Care, Vol. 21, Iss. 3, 2013-08 ,pp. : 187-188

Radcliffe Press

Access to resources Recommend Favorite

Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective

By Karnon Jonathan  

The European Journal of Health Economics, Vol. 9, Iss. 2, 2008-05 ,pp. : 171-183

Springer Publishing Company

Access to resources Recommend Favorite